Price Over Earnings Overview: Regeneron Pharmaceuticals

Why did Arm Holdings' stock drop after earnings? How will Trump's tariffs affect US carmakers? What is the impact of US-China trade talks? Why did OpenAI hire Instacart's CEO? How did the Federal Reserve respond to tariffs? What caused WeightWatchers to file for bankruptcy? Why is Disney opening a theme park in Abu Dhabi? How are Trump’s tariffs affecting toy prices? What led to Uber CEO’s return-to-office backlash?

Price Over Earnings Overview: Regeneron Pharmaceuticals

benzinga.com/insights/news/25/05/45254301/price-over-earnings-overview-regeneron-pharmaceuticals

In the current market session, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) price is at $563.91, after a 0.97% increase. However, over the past month, the stock fell by 2.22%, and in the past year, by 41.74%. Shareholders might be interested in knowing whether the stock is undervalued,…

This story appeared on benzinga.com, 2025-05-07 14:00:26.